AKSO is at the forefront of innovation, harnessing critical components of immune biology and the tissue microenvironment to effectively target cancer, autoimmune disorders, and fibrotic diseases. Our dedication to cutting-edge research is not just advancing protein science—it’s redefining the future of medicine.